APA

Zecevic L., Mekic M., Subasic D., Hadziabulic M., Isak E., Subasic E. & Selmanovic K. (20200701). Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment. : Medical archives (Sarajevo, Bosnia and Herzegovina).

Chicago

Zecevic Lamija, Mekic Mevludin, Subasic Djemo, Hadziabulic Majda, Isak Edmira, Subasic Emina and Selmanovic Kenan. 20200701. Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment. : Medical archives (Sarajevo, Bosnia and Herzegovina).

Harvard

Zecevic L., Mekic M., Subasic D., Hadziabulic M., Isak E., Subasic E. and Selmanovic K. (20200701). Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment. : Medical archives (Sarajevo, Bosnia and Herzegovina).

MLA

Zecevic Lamija, Mekic Mevludin, Subasic Djemo, Hadziabulic Majda, Isak Edmira, Subasic Emina and Selmanovic Kenan. Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment. : Medical archives (Sarajevo, Bosnia and Herzegovina). 20200701.